Brad Goad Patient Family

I am one of the brothers on Team Goad riding in support of my brother Jeff (one of the Survivors of MM). I have participated in several marathons with brothers Jeff and Dave over the last 11 years. In 2019, we switched over and started participating in the Road to Victories component for Multiple Myeloma and along with brother David to provide the “training wheels for Jeff” to help him get from start to finish. I want to ride to help not only my brother but all of the other survivors and future individuals who encounter this cancer. I look forward to meeting everyone in person as we ensure a six day bike trip in Oregon traversing 247 miles with approximately 13900′ of elevation gain. “One mile, one hill, one dollar at a time!”

Sorry, there are no posts from this member.
The mission of the Multiple Myeloma Research Foundation (MMRF) is to find a cure for multiple myeloma by relentlessly pursuing innovation that accelerates the development of next-generation treatments to extend the lives of patients. Founded in 1998 by Kathy Giusti, a multiple myeloma patient, and her twin sister Karen Andrews as a 501(c) (3) nonprofit organization, the MMRF is a world-recognized leader in cancer research. Together with its partners, the MMRF has created the only end-to-end solution in precision medicine and the single largest genomic dataset in all cancers. The MMRF continues to disrupt the industry today, as a pioneer and leader at the helm of new research efforts. Since its inception, the organization has raised over $400 million and directs nearly 90% of the total funds to research and related programs. Learn more and sign up to receive news and resources from the MMRF.

Learn More

At Janssen Oncology, we’re shaping the future of cancer treatment. In the process, we’re striving to change expectations of what a cancer diagnosis means. Our purpose is driven by an urgency and commitment to bringing transformational cancer solutions to the people who need them. Passionate about our work, we are driven by the personal connection many of us share with the disease. With our partners, we focus on delivering solutions that make a positive impact on human health. We are part of Janssen Biotech, Inc., and the Janssen Pharmaceutical Companies of Johnson & Johnson.

About Janssen Oncology

Click below to learn more about a treatment option for multiple myeloma. If you’re also interested in getting more information from Janssen, sign up for ongoing communications.

Learn More